JPRN-UMIN000000953已完成2 期
Phase II study of pre-emptive therapy against CMV-associated disesase by valganciclovir after allogeneic hematopoietic stem cell transplantation - Pre-emptive therapy against CMV-associated disesase by valganciclovir after allogeneic hematopoietic stem cell transplantation
Dept of 1st Intern Med, Kyushu Univ Hospital0 个研究点目标入组 10 人开始时间: 2008年4月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Negative CMV-Ab of both donor and recipient cord blood transplantion T-cell depleted or CD34-positive cell selected transplantion Gut GVHD (>=stage 2) HLA more than 2 locus disparity
研究者
相似试验
已完成
1 期
Phase I study of CMV specific CTL for treatment of refractory CMV infection after allogeneic hematopoietic stem cell transplantatioRefractory CMV infection after allogeneic hematopoietic stem cell transplantationJPRN-UMIN000001749Department of Pediatrics, Nagoya University Graduate School of Medicine5
招募中
1 期
CMV preemptive therapy in high-risk immunocompetent major heart surgery patients. A multicenter, double blind, randomized, clinical trial (GAN-CAR).CTIS2022-501429-19-00Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon226
已完成
2 期
TAMOVALCIR in Allogenic Hematopoietic Progenitors TransplantCytomegalovirus InfectionNCT00386412PETHEMA Foundation132
招募中
不适用
Prephase treatment in elderly DLBCKCT0003916Kosin University Gospel Hospital37
进行中（未招募）
不适用
Phase I/II trial of vaccine therapy in curative resected prostate cancer patients using autologous dendritic cells loaded with mRNA from primary prostate cancer tissue, hTERT and surviving.Prostatic cancer patients who have received curative surgery.EUCTR2010-018770-20-NOOslo University Hospital30